Amyloid A amyloidosis is thought to be the second most common form of systemic
amyloidosis behind amyloidosis secondary to monoclonal Ig. It is the result of deposition of …

Secondary renal amyloidosis (RA) is the most common type of renal involvement in
ankylosing spondylitis (AS). We assessed the epidemiologic and clinico-biological profile of …

Objective: Patients with psoriatic arthritis (PsA) or rheumatoid arthritis (RA) commonly
develop renal dysfunction due to either systemic inflammation or drug-related nephrotoxicity …

Biologic therapy for amyloid A amyloidosis secondary to rheu... : Medicine Biologic therapy for
amyloid A amyloidosis secondary to rheumatoid arthritis treated with interleukin 6 therapy …

Objectives: Describe the indications for biologic response modifiers. Identify the adverse
events associated with biologic response modifiers. Review the importance of monitoring …

This study aimed to explore the associations of COX‐2 polymorphisms rs5275, rs20417, and
rs2745557 with the susceptibility to ankylosing spondylitis among Chinese Han people …

В статье рассматриваются основные варианты поражения почек при системных
аутоиммунных и аутовоспалительных заболеваниях, в том числе гломерулонефрит …

Amyloidoza AA jest powikłaniem przewlekłych chorób związanych z aktywacją białek ostrej
fazy. Prekursorem amyloidu jest białko surowiczego amyloidu A. Nerki są najczęściej …

The current modern treatment for Rheumatoid Arthritis is the genetically engineered
biological drug rituximab. This drug helps to low the active rheumatoid arthritis. The aim of …

AA amyloidosis is a complication of chronic diseases associated with the activation of acute
phase reactants. The precursor of amyloid is the serum amyloid A. The kidneys are the most …